Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: techmover, Penny Traders Club, Top Penny, bz777, UndervaluedStocks, HighYieldStocks
Search This Board: 
Last Post: 6/24/2017 11:41:56 AM - Followers: 395 - Board type: Free - Posts Today: 7



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#46897  Sticky Note ARYC is a Silicon Valley company that is UndervaluedStocks 06/07/17 02:40:15 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#45708  Sticky Note NEW...Arrayit to double manufacturing capacity by 6/30/2017 to HighYieldStocks 05/08/17 11:49:19 AM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates StockZoom 02/08/17 10:32:34 AM
#47529   VERY NICE!!! getmoreshares 06/24/17 11:41:56 AM
#47528   $122000 plus other sales without specific amount millions213 06/24/17 09:41:52 AM
#47527   ARYC....GOOD JOB.!!....GREAT DD....Keep up the GOOD WORK...GLTA tm1119 06/24/17 09:23:45 AM
#47526   Word up! TravO 06/24/17 06:50:50 AM
#47525   LOOK at this I did some DD millions213 06/24/17 03:43:53 AM
#47524   $122,000 in sales yesterday! UndervaluedStocks 06/24/17 12:22:01 AM
#47523   For all new ARYC investors: There is going to UndervaluedStocks 06/24/17 12:21:05 AM
#47522   I was happy to be part of that Meq 06/23/17 09:22:10 PM
#47520   what does short volume mean? please be specific. lucky,mydog 06/23/17 08:12:13 PM
#47519   But here in the real world. yorky 06/23/17 06:55:46 PM
#47517   1.8 million .007's were bought today....great day my UndervaluedStocks 06/23/17 05:48:28 PM
#47516   Look at ARYC three-year weekly chart, there is Ken1998 06/23/17 05:29:37 PM
#47515   Accumulate before ARYC goes to $1+ UndervaluedStocks 06/23/17 05:15:52 PM
#47514   accumulate before the suspension. lucky,mydog 06/23/17 04:58:38 PM
#47512   Better yet, look at the 180 day chart. hitzey 06/23/17 04:36:14 PM
#47511   Agree- the longer it stays at this level bz777 06/23/17 04:15:02 PM
#47510   Look at the 90 day chart. Accumulation is UndervaluedStocks 06/23/17 04:07:33 PM
#47509   Next week will be Beautiful for ARYC :)) PowerPlay1 06/23/17 04:03:23 PM
#47508   I agree DD says this is going. simmons420 06/23/17 03:19:01 PM
#47507   Hit my share goal today$$$ Good Luck All Meq 06/23/17 02:23:17 PM
#47506   Arrayit reports $58,700 microarray services sale to a UndervaluedStocks 06/23/17 02:21:58 PM
#47505   Arrayit reports $71,500 microarray technology sale to a UndervaluedStocks 06/23/17 02:20:42 PM
#47504   Arrayit reports microarray technology sale to top European UndervaluedStocks 06/23/17 02:19:39 PM
#47503   Arrayit reports $47,700 microarray services sale to top UndervaluedStocks 06/23/17 02:18:57 PM
#47502   more promising tweets today: bz777 06/23/17 02:04:54 PM
#47501   Who cares who contacted whom? They received Alyssa 06/23/17 12:58:21 PM
#47500   Great post from 4 years ago.....LOL!!! UndervaluedStocks 06/23/17 12:56:53 PM
#47499   nice - i agree! bz777 06/23/17 12:54:39 PM
#47498   Get to .01 and we run$$$$$ PowerPlay1 06/23/17 12:53:38 PM
#47497   I always think of Ronald Reagan on days a surfer 06/23/17 12:49:08 PM
#47496   Key word is proposal. Give some details. Pencow 06/23/17 12:46:41 PM
#47495   One of the most hysterical bogus proposals from MikeCr 06/23/17 12:39:26 PM
#47494   .007's getting hit hard! bz777 06/23/17 12:35:58 PM
#47493   .006's gone!! .007's are up!! UndervaluedStocks 06/23/17 12:33:13 PM
#47492   7's going today - power for a Friday- bz777 06/23/17 12:27:38 PM
#47491   After the .007's are gone, watch ARYC fly UndervaluedStocks 06/23/17 12:22:47 PM
#47490   ARYC breakout is coming soon! Ken1998 06/23/17 12:22:21 PM
#47487   ARYC is NOT a P&D company. This is Penny Traders Club 06/23/17 12:08:48 PM
#47486   proposals schmosals. MikeCr 06/23/17 12:06:51 PM
#47485   NEW...Arrayit receives daily update for completing our audit HighYieldStocks 06/23/17 12:05:50 PM
#47484   ARYC....THANK YOU!!...THAT TWEET WAS H.U.G.E.!...THIS COULD BE ARYC tm1119 06/23/17 11:58:22 AM
#47482   yes good time for anyone to exit if bz777 06/23/17 11:47:22 AM
#47481   NEW...Arrayit reports $71,500 microarray technology sale to a HighYieldStocks 06/23/17 11:46:30 AM
#47480   Next week financials will be released silver to dollars$$ PowerPlay1 06/23/17 11:39:20 AM
#47479   additional documents provided for audit completion is key whento 06/23/17 11:37:31 AM
#47478   Notice every buy stock moves up. FLOAT LOCKED$$$ PowerPlay1 06/23/17 11:29:01 AM
#47476   1.4 million on the bid at .0067!!!! WOW!!!! UndervaluedStocks 06/23/17 11:26:50 AM
#47475   Look at that fake block Penny Traders Club 06/23/17 10:51:16 AM
#47474   .0067's are dropping UndervaluedStocks 06/23/17 10:46:49 AM
#47473   Not cryptic at all. Business Expansion proposal! Alyssa 06/23/17 10:21:39 AM